Have definitely read that too, but now for the life of me can find any particulars. Last I saw it mentioned was in this release from MGC Pharma as "...clear federal legislative and regulatory framework now expected to be in place during February 2018", so perhaps there's only been vague unsubstantial statements made. Nothing I can find on Gov sites or parliament sites discusses in much depth...maybe the word "expected" can be read into more in this instance. If it were already cemented in we would be flying right now.
IMO if the last statements bumped it up so far this statement will de-risk to a point that larger investors or older more sceptical investors will come on board. Hold or buy more I think, esp if we are coming to the initial offer date and we see a CGT avoiding sell-down lowering the prices.
Release link:
http://www.aspecthuntley.com.au/asxdata/20180105/pdf/01939340.pdf
DYOR as always
Good luck to all
- Forums
- ASX - By Stock
- AC8
- February MM Legislation
February MM Legislation, page-2
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable